AI assistant
Core Scientific, Inc./tx — Director's Dealing 2026
Jan 5, 2026
30992_dirs_2026-01-05_9d224aca-d499-446d-982f-544a4f666728.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Core Scientific, Inc./tx (CORZ)
CIK: 0001839341
Period of Report: 2025-12-31
Reporting Person: DUCHENE TODD M (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Common Stock | A | 55758 | — | Acquired | 2077880 | Direct |
| 2025-12-31 | Common Stock | F | 139873 | $15.08 | Disposed | 1938007 | Direct |
Footnotes
F1: Represents the acquisition of additional performance-based restricted stock units in connection with the 300% vesting of the second installment of the Reporting Person's performance-based restricted stock units granted on July 19, 2024, and previously reported at 100% vesting in the Form 4 filed by the Reporting Person on July 22, 2024.
F2: Reported amount reflects the acquisition of 694 shares of Common Stock that the Reporting Person received on October 27, 2025 on an involuntary basis for no consideration in an in-kind distribution on a pro rata basis from a reserve of shares of Common Stock held for certain claims settlement matters in connection with previous bankruptcy proceedings of the Issuer, which was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-9 under the Exchange Act.
F3: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.